Supporter News
Day 1: Friday, 27 September 2024 – A Strong Start to CLL Horizons 2024
The first day of CLL Horizons 2024 began at noon with a warm Opening Lunch on the Evolution Terrace, where participants were welcomed by the event team. Over lunch, attendees were introduced to the structure of the conference and received guidance on navigating the sessions ahead. Don’t miss the highlights! View our 2-minute video recap below. Workshops: Building…
Financial Times: Improving AML Patient Care
https://acutemyeloidleukaemia.live.ft.com/ Discussion topics include: What is the experience and unmet needs of AML patients, families and carers, and the challenges they are facing? What is their view of how their diagnosis, treatment, care and support could be improved? What are the cost drivers of AML treatment and care, and how might new drugs, diagnostics, new…
Registration for attending CLL Horizons 2024 in-person is now closed. Final call for virtual registration!
The CLL Advocates Network (CLLAN) Steering Committee is thrilled to announce the return of our highly anticipated in-person event after the pandemic hiatus. Our 5th conference promises a blend of in-person and virtual experiences scheduled for 27th – 29th September in Barcelona, Spain. Final call for virtual registration! – CLICK HERE TO REGISTER Draft Agenda: You can view draft…
Spotlight on ALAN members
In 2024, with ALAN support, some of our members have been able to start and/or complete projects which benefit acute leukemia patients and their families. We are very grateful that our support could contribute to make these projects happen. Aim: provide accurate and comprehensive information to support shared decision-making among those impacted by acute leukemia,…
1 SEPTEMBER IS WORLD CLL DAY – CAMPAIGN TOOLKIT NOW AVAILABLE FOR YOU TO USE!
Dear friends of the CLL Advocates Network Every 1 September, the global CLL community unites to raise awareness about chronic lymphocytic leukemia (CLL) and give those affected by a diagnosis of CLL a much-needed voice. On World CLL Day we come together to improve understanding of the vulnerability of CLL patients and the challenges involved…
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway Webinar
On 9 July at 10:30 am EDT/4:30 pm CET, experts will recap the latest data from EHA 2024, speculate on how it may fit into treatment guidelines, and consider how best to incorporate recent advances into the treatment algorithm. They will discuss the key factors to consider when selecting a therapy for a patient and…
EHA 2024
From 12th to 16th June, ALAN attended the European Hematology Association (EHA) 2024 congress, held in Madrid, Spain. Below is a summary of the activities in which ALAN took part, in addition to meeting with our members, sponsors and with the medical community. We are also reporting on the key sessions and latest advances. Check here…
Highlights from EHA – Infographic gallery
Download your copy and discover the core insights from EHA Congress, condensed into a dynamic infographic. Acute promyelocytic LEUKEMIA (APL) FIRST RESULTS OF THE APOLLO TRIAL: A RANDOMIZED PHASE III STUDY TO COMPARE ATO COMBINED WITH ATRA VERSUS STANDARD AIDA REGIMEN FOR PATIENTS WITH NEWLY DIAGNOSED, HIGH-RISK APL APL APOLLO Trial Acute lymphoblastic leukemia (ALL)…
Proudly welcoming another new member: The CLLAN now counts 54 members from 44 countries!
We are proud to welcome a new member to our network! Please join us in welcoming Henzo Kenya, our first member from Kenya! HENZO KENYA, is a Community Based Organisation Registered in Kenya. It brings together about 1,500 cancer patients for awareness, mutual support and advocacy. Most of the patients (about 80%, are on treatment…
WEBINAR: “Latest News from EHA 2024”
Dear members & friends, We are excited to announce a special webinar focusing on the latest advancements in Myeloproliferative Neoplasms (MPN) research, as presented at the EHA Congress 2024. Join us for an in-depth discussion led by esteemed experts in the field, Susanne Isfort from the University of Hannover and Heike Pahl from the University…
